ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Streamlining The Path To Market For Generic Drug-Device Combinations

  Developing g-DDCPs is a complex and time-consuming process. By using a risk-based approach, manufacturers can streamline the development process and bring g-DDCPs to market more quickly.

• Nasal Inhalation Delivery – An Introduction Guide

  Unlock the potential of nasal inhalation for delivering active pharmaceutical ingredients by exploring the benefits of both liquid and dry powder formulations as companies drive innovation in the field.

• 5 Ways Pre-Filled Syringes Contribute To Better Patient Outcomes

  In our series on pre-filled syringes, we explore five key ways this delivery format is enhancing patient outcomes, not just through the medicine it contains, but through the device design itself.

• Streamlining Primary Container And Device Selection With Predictive Calculations

  Expolore a theoretical approach to complement experimental approaches to more quickly select a packaging and delivery system for your drug product.

• Key Considerations For Dry Powder Inhalation

  A focus on spray-drying expertise in pulmonary and nasal powder development highlights why it is vital to choose the right CDMO.

• Characterizing The E&L Profile Of Stoppers For Drug Stability

  The significance of E&L testing lies in its ability to identify potential risks associated with the use of containers and packaging materials in the pharmaceutical industry.

• Are Drugs Becoming More Lipophilic Over Time?

  Get a deeper look into how drug lipophilicity has evolved over time, its impact on drug development, and the need for new technology to enable new more complex drugs.

• Delivering On GLP-1 Demand: Combining Device And Supply Strategy

  Meeting the demand for GLP-1 treatments requires robust and efficient delivery systems. Review how innovative solutions offer customization, streamlined manufacturing, and formulation compatibility.

• Most Frequently Asked Questions On The Revised EU GMP Annex 1: Volume 7

  Modernize your sterile manufacturing approach. Explore essential insights on contamination control strategies, risk management, and barrier technologies to ensure full regulatory alignment.

• Most Frequently Asked Questions On The Revised EU GMP Annex 1: Volume 8

  Successfully implementing a site-wide CCS requires prioritizing barrier technologies, integrating primary packaging into risk assessments, and adopting a data-driven approach to environmental monitoring.